p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy
- Hyeon Jeong Oh
- , Jeong Mo Bae
- , Xianyu Wen
- , Seorin Jung
- , Younghoon Kim
- , Kyung Ju Kim
- , Nam Yun Cho
- , Jung Ho Kim
- , Sae Won Han
- , Tae You Kim
- , Gyeong Hoon Kang
- Seoul National University
Research output: Contribution to journal › Article › peer-review
42
Scopus
citations